NovaBridge Biosciences NBP Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises 508 JTAI Q1 2026 Earnings Deep EPS Miss Despite Positive Stock Movement FiscalNote Q1 2026 Earnings EPS Surprise Beats Estimates Despite Stock Decline GFL Q1 2026 Earnings EPS Misses Estimates Amidst Cost Pressures RenovoRx Q1 2026 Earnings EPS Miss as PreRevenue Biotech Continues Clinical Development TELO Q4 2025 Earnings EPS Misses Estimates by 292 as Cash Burn Continues No Revenue Reported